The Bombay High Court has allowed Johnson & Johnson to resume manufacturing of baby powder at its Mulund plant, which has been ordered to stop by the Maharashtra Food and Drug Administration.

J&J offered test batches, and no carcinogens were found.

A J&J spokesperson commented, “Nothing is more important to us than the well-being of consumers, and we see this outcome as a significant step in restoring their confidence. We will continue to work closely with Maharashtra FDA, and provide India with safe, high quality products that help people care for themselves and their families.”